Tower Research Capital »

Viracta Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Viracta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.1k 5.1k 1.00
2023-06-30 $7.1k 5.0k 1.41
2023-03-31 $26k 16k 1.67
2022-12-31 $22k 15k 1.45
2022-09-30 $7.2k 2.1k 3.37
2022-06-30 $4.0k 908 4.41
2022-03-31 $9.0k 1.9k 4.81
2021-12-31 $23k 6.4k 3.60
2021-09-30 $7.0k 927 7.55
2021-06-30 $7.0k 641 10.92
2021-03-31 $59k 6.4k 9.24